Efg Asset Management (Americas) Corp. Roivant Sciences Ltd. Transaction History
Efg Asset Management (Americas) Corp.
- $508 Million
- Q4 2024
A detailed history of Efg Asset Management (Americas) Corp. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Efg Asset Management (Americas) Corp. holds 155,452 shares of ROIV stock, worth $1.64 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
155,452
Previous 159,937
2.8%
Holding current value
$1.64 Million
Previous $1.85 Million
0.38%
% of portfolio
0.36%
Previous 0.36%
Shares
6 transactions
Others Institutions Holding ROIV
# of Institutions
329Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$692 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$653 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$503 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$464 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$372 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.41B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...